Periodontitis is an inflammatory disease that causes destruction of the tooth-supporting tissues and may adversely affect systemic health. The proper function of homeostatic mechanisms is essential for protection against unwarranted inflammatory tissue damage. The endothelial cell-secreted protein Del1 (encoded by the EDIL3 gene) acts homeostatically in vivo to regulate neutrophil transmigration and local inflammation in the periodontal tissue. However, Del1 expression is diminished in old age or by certain inflammatory stimuli. Preliminary studies also suggest that Del1 is additionally expressed by and regulates osteoclasts. Therefore, Del1 can potentially act as a gatekeeper of inflammation and may have important therapeutic implications. The overall objective of this application is to understand how Del1 expression is regulated at the molecular signaling level, define novel Del1 functions, and identify key functional sites within the Del1 polypeptide that could be exploited as anti-inflammatory drugs. The proposed approach is based on in vitro and in vivo experimental systems in mice (wild-type and Del1-deficient) and non-human primates and in vitro human assays for transmigration, osteoclastogenesis, and Del1 regulation. The overarching hypothesis of this proposal is that Del1 is a functionally versatile molecule which acts homeostatically to regulate critical upstream and downstream events that lead to inflammatory bone loss, and, therefore, has therapeutic potential for the treatment of periodontitis.
Four Specific Aims are proposed.
Aim 1 will determine the role and mechanism(s) of Del1 in the differentiation and function of osteoclasts.
Aim 2 involves the dissection of signaling pathway(s) regulating Del1 expression.
Aim 3 involves the functional mapping of domains of Del1 essential for regulating neutrophil transmigration or osteoclastogenesis.
Aim 4 will determine the efficacy of local treatment with Del1 (or domains thereof) in experimental periodontitis in non-human primates. The long- term goal of this project is to establish Del1 (or Del1-derived segments) as an effective adjunctive treatment for human periodontitis. As the protective role of Del1 is suspected in additional inflammatory conditions, this proposal may have implications beyond the treatment of periodontitis. Importantly, since Del1 is an endogenous molecule the expression of which is diminished in inflammatory disorders, the local administration of recombinant Del1 (or segments thereof) in inflammatory conditions is unlikely to involve safety issues, but rather should restore tissue homeostasis.

Public Health Relevance

Periodontitis causes destruction of the tooth-supporting tissues and may adversely affect systemic health, although conventional treatments are often not sufficient to control destructive periodontal inflammation. Preliminary studies indicate that the endothelial cell-secreted protein Del1 acts as a gatekeeper of inflammatory bone loss by regulating the recruitment of inflammatory cells and the differentiation of osteoclasts (bone-resorbing cells). The proposed studies aim to elucidate how Del1 expression is regulated, define its mechanisms of action, and identify key functional sites within the Del1 polypeptide that could be exploited as anti-inflammatory drugs in periodontitis and other inflammatory conditions.

National Institute of Health (NIH)
National Institute of Dental & Craniofacial Research (NIDCR)
Research Project (R01)
Project #
Application #
Study Section
Oral, Dental and Craniofacial Sciences Study Section (ODCS)
Program Officer
Chander, Preethi
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Pennsylvania
Schools of Dentistry/Oral Hygn
United States
Zip Code
Chen, Lan-Sun; Kourtzelis, Ioannis; Singh, Rashim Pal et al. (2018) Endothelial Cell-Specific Overexpression of Del-1 Drives Expansion of Haematopoietic Progenitor Cells in the Bone Marrow. Thromb Haemost :
Lamont, Richard J; Koo, Hyun; Hajishengallis, George (2018) The oral microbiota: dynamic communities and host interactions. Nat Rev Microbiol 16:745-759
Bostanci, Nagihan; Bao, Kai; Li, Xiaofei et al. (2018) Gingival Exudatome Dynamics Implicate Inhibition of the Alternative Complement Pathway in the Protective Action of the C3 Inhibitor Cp40 in Nonhuman Primate Periodontitis. J Proteome Res 17:3153-3175
Mitroulis, Ioannis; Ruppova, Klara; Wang, Baomei et al. (2018) Modulation of Myelopoiesis Progenitors Is an Integral Component of Trained Immunity. Cell 172:147-161.e12
Hajishengallis, George; Korostoff, Jonathan M (2017) Revisiting the Page & Schroeder model: the good, the bad and the unknowns in the periodontal host response 40 years later. Periodontol 2000 75:116-151
Kajikawa, Tetsuhiro; Briones, Ruel A; Resuello, Ranillo R G et al. (2017) Safety and Efficacy of the Complement Inhibitor AMY-101 in a Natural Model of Periodontitis in Non-human Primates. Mol Ther Methods Clin Dev 6:207-215
Kajikawa, Tetsuhiro; Meshikhes, Fatimah; Maekawa, Tomoki et al. (2017) Milk fat globule epidermal growth factor 8 inhibits periodontitis in non-human primates and its gingival crevicular fluid levels can differentiate periodontal health from disease in humans. J Clin Periodontol 44:472-483
Mitroulis, Ioannis; Chen, Lan-Sun; Singh, Rashim Pal et al. (2017) Secreted protein Del-1 regulates myelopoiesis in the hematopoietic stem cell niche. J Clin Invest 127:3624-3639
Olsen, Ingar; Lambris, John D; Hajishengallis, George (2017) Porphyromonas gingivalis disturbs host-commensal homeostasis by changing complement function. J Oral Microbiol 9:1340085
Klotzsche-von Ameln, Anne; Cremer, Sebastian; Hoffmann, Jedrzej et al. (2017) Endogenous developmental endothelial locus-1 limits ischaemia-related angiogenesis by blocking inflammation. Thromb Haemost 117:1150-1163

Showing the most recent 10 out of 32 publications